In 1990 was created Brookside Capital, which is appeared as VC. The main office of represented VC is situated in the San Francisco. The fund was located in North America if to be more exact in United States.
The top activity for fund was in 2015. The typical startup value when the investment from Brookside Capital is more than 1 billion dollars. The top amount of exits for fund were in 2014. This Brookside Capital works on 33 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in 2-6 deals every year. The real fund results show that this VC is 2 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 50 - 100 millions dollars.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Brookside Capital, startups are often financed by MPM Capital, Wellcome Trust, Sutter Hill Ventures. The meaningful sponsors for the fund in investment in the same round are Sutter Hill Ventures, Skyline Ventures, MPM Capital. In the next rounds fund is usually obtained by Sutter Hill Ventures, Oxford Finance LLC, Meritech Capital Partners.
Besides them, we counted 3 critical employees of this fund in our database.
Among the most popular fund investment industries, there are Biopharma, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight MuleSoft, Spark Therapeutics, DocuSign. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
Fund Name | Location |
4DX | Australia, Melbourne, Victoria |
Action Potential Venture Capital | Cambridge, Massachusetts, United States |
Arm China | - |
Highnote Foundry | New York, New York, United States |
Martin Currie | City of Edinburgh, Scotland, United Kingdom |
Nautica | New York, New York, United States |
RSP Architects | Minneapolis, Minnesota, United States |
Sorbon Investments | Beaconsfield, Buckinghamshire, United Kingdom |
Space Angels | New York, New York, United States |
Vault | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Socar | $56M | 27 Nov 2015 | South Korea, Gyeonggi-do, South Korea | ||
SevOne | $47M | 23 Sep 2015 | Boston, Massachusetts, United States | ||
Translate Bio | $63M | 23 Jul 2015 | Cambridge, Massachusetts, United States | ||
Qoo10-Indonesia | $82M | 20 Jul 2015 | Surabaya | ||
Voyager Therapeutics | $60M | 13 Apr 2015 | Cambridge, Massachusetts, United States | ||
REGENXBIO | $30M | 21 Jan 2015 | Maryland, United States | ||
Spark Therapeutics | $72M | 27 May 2014 | Philadelphia, Pennsylvania, United States | ||
Dicerna Pharmaceuticals | $60M | 31 Jul 2013 | Massachusetts, United States | ||
Radius Health | $66M | 26 Jul 2011 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Socar | $56M | 27 Nov 2015 | South Korea, Gyeonggi-do, South Korea | ||
SevOne | $47M | 23 Sep 2015 | Boston, Massachusetts, United States | ||
Translate Bio | $63M | 23 Jul 2015 | Cambridge, Massachusetts, United States | ||
Qoo10-Indonesia | $82M | 20 Jul 2015 | Surabaya | ||
Voyager Therapeutics | $60M | 13 Apr 2015 | Cambridge, Massachusetts, United States | ||
REGENXBIO | $30M | 21 Jan 2015 | Maryland, United States | ||
Spark Therapeutics | $72M | 27 May 2014 | Philadelphia, Pennsylvania, United States | ||
Dicerna Pharmaceuticals | $60M | 31 Jul 2013 | Massachusetts, United States | ||
Radius Health | $66M | 26 Jul 2011 | Cambridge, Massachusetts, United States |